Fatty Liver Stools: Colours, Signs and When to Act

Fatty liver stool changes are a concern for many people diagnosed with, or worried about, metabolic dysfunction-associated steatotic liver disease (MASLD). In most cases, early fatty liver causes no visible change to stools at all. Stool colour and texture are primarily governed by bile flow, and it is only when bile production or secretion becomes significantly impaired, typically in more advanced liver disease or biliary obstruction, that noticeable changes occur. This article explains what stool changes can indicate, why they happen, which bowel symptoms may be associated with fatty liver, and when to seek medical advice.

What does your stool look like when you have fatty liver?

Early fatty liver usually causes no stool changes; pale, clay-coloured, or greasy stools are signs of advanced liver disease or biliary obstruction, not simple fatty liver, and always require GP assessment.

In early or mild fatty liver disease (also called metabolic dysfunction-associated steatotic liver disease, or MASLD), most people notice no change in their stools at all, and bowel habits remain largely normal.^[1][2] Stool appearance tends to change only when the liver's ability to produce or secrete bile becomes significantly impaired, which is more typical of advanced liver disease, biliary obstruction, or cholestasis than of simple fatty liver.

Bile is a yellow-green digestive fluid produced by the liver and stored in the gallbladder. It gives stools their characteristic brown colour. When bile flow is substantially reduced, stools can become noticeably lighter. In conditions where bile ducts become obstructed, such as gallstones, biliary strictures, or advanced liver disease including cirrhosis, stools may appear pale, grey, clay-coloured, or almost white. This is sometimes described clinically as acholic stool and is a sign of cholestasis rather than a typical feature of early MASLD. Persistent pale or white stools accompanied by yellowing of the skin or eyes (jaundice) and dark urine require same-day urgent assessment, not a routine appointment.

Stools may also appear greasy or bulky. This happens because fat is not being properly absorbed in the gut, a consequence of insufficient bile reaching the small intestine. Fatty, foul-smelling stools that are difficult to flush are sometimes referred to as steatorrhoea. It is important to note that steatorrhoea is uncommon in simple fatty liver and has several other important causes, including pancreatic exocrine insufficiency, coeliac disease, bile duct obstruction, and certain medicines such as orlistat.^[6] Floating stools are also non-specific and are not a reliable marker of fat malabsorption on their own.

Pale, greasy, or floating stools alone do not confirm fatty liver disease. A GP assessment is always needed to investigate the underlying cause, and self-diagnosis should be avoided.

Why does fatty liver affect the colour and texture of stools?

Stool colour is determined by bile pigments, not liver fat content; reduced bile flow causes pale stools, while fat malabsorption from insufficient bile causes greasy stools, both more typical of advanced disease than early MASLD.

Stool colour and texture are primarily determined by bile flow rather than by the fat content of liver cells. Bile pigments, particularly bilirubin, are responsible for the brown colour of normal stools.^[5] When bile delivery to the small intestine is reduced, less bilirubin reaches the gut and stools become paler.

In simple fatty liver (MASLD), bile synthesis is not usually impaired to a degree that causes visible stool changes. Pale or acholic stools are more typically a sign of cholestasis, which occurs when bile flow is obstructed or significantly reduced. This can result from gallstones blocking the bile duct, inflammation causing biliary strictures, or advanced liver disease such as cirrhosis with associated portal hypertension. Extrahepatic causes, including pancreatic disease compressing the bile duct, are also important differentials.

The texture of stools is affected when fat malabsorption occurs. Without adequate bile reaching the duodenum, dietary fats pass through the intestine largely undigested, resulting in greasy, loose, or bulky stools (steatorrhoea). This is more commonly seen in advanced liver disease or biliary obstruction rather than in simple fatty liver, and pancreatic exocrine insufficiency and coeliac disease are at least as common a cause.

Some research suggests that liver inflammation may influence gut motility and the composition of the gut microbiome, which could affect stool consistency and frequency. However, this is an area of ongoing investigation and the clinical significance in MASLD specifically is not yet established. Stool changes are generally a later sign of liver disease rather than an early warning, and their presence should prompt investigation for a range of possible causes.

Which other bowel changes can fatty liver cause?

Most people with early MASLD have no bowel changes, but bloating, nausea, and loose stools can occur; in advanced cirrhosis, portal hypertension may cause gastrointestinal bleeding, presenting as melaena or bright red rectal bleeding.

Beyond changes in stool colour and texture, fatty liver disease can be associated with a range of other bowel symptoms, though it is important to emphasise that most people with early MASLD have no bowel changes at all. Many of the symptoms described below are non-specific and may have other causes unrelated to the liver.

Bloating and abdominal discomfort are among the most commonly reported symptoms, often felt in the upper right abdomen where the liver sits. These symptoms can result from liver enlargement (hepatomegaly) pressing on surrounding structures, or from altered gut function, but they are also common in many other conditions including irritable bowel syndrome, gallbladder disease, and functional dyspepsia.

Nausea is another frequently reported symptom, particularly after eating fatty meals, and may be accompanied by a reduced appetite. Some people with fatty liver disease also experience changes in bowel frequency, including loose stools or, less commonly, constipation. These changes are non-specific and should not be attributed to fatty liver without proper assessment.

In more advanced liver disease, such as cirrhosis, a serious complication called gastrointestinal bleeding can occur. This happens when increased pressure in the portal vein (portal hypertension) causes blood vessels in the oesophagus or stomach to enlarge and rupture. Blood in the stool may appear bright red if the bleeding is in the lower gut, or black and tarry (melaena) if it originates higher up in the digestive tract.^[12]

Melaena (black, tarry stools) is a medical emergency and requires immediate attention: call 999 or go to your nearest accident and emergency department. For heavy or ongoing bright red rectal bleeding, or if you feel faint, pale, or unwell, also call 999 or go to A&E. For smaller amounts of fresh rectal bleeding without these features, contact your GP urgently or call NHS 111 for guidance. Most people with early fatty liver disease will not experience these severe complications, but awareness of the warning signs is essential.

When should you see a GP about changes to your stools?

Seek same-day urgent assessment for jaundice with pale stools and dark urine; call 999 or go to A&E for melaena or heavy rectal bleeding; book a routine GP appointment for persistent greasy stools or abdominal discomfort.

You should seek same-day urgent assessment if you notice persistent pale, grey, or clay-coloured stools accompanied by yellowing of the skin or eyes (jaundice) and dark urine. Together, these symptoms suggest that bile flow is significantly impaired and require prompt investigation. Do not wait for a routine appointment: contact your GP surgery for an urgent same-day appointment, or call NHS 111 if your GP is unavailable. A GP can arrange blood tests, including liver function tests (bilirubin, alkaline phosphatase, ALT, and GGT), and may refer you for an abdominal ultrasound scan to assess the liver and bile ducts.

Certain stool changes require more urgent action. Melaena (black, tarry stools) or heavy or ongoing bright red rectal bleeding, particularly if accompanied by feeling faint, pale, or unwell, should be treated as a medical emergency: call 999 or go to your nearest accident and emergency department immediately, as these may indicate serious gastrointestinal bleeding. For smaller amounts of fresh rectal bleeding without these features, contact your GP urgently or call NHS 111.

For less acute but persistent changes, such as greasy or floating stools, unexplained weight loss, or ongoing abdominal discomfort, a routine GP appointment is appropriate. If painless obstructive jaundice is suspected, your GP may refer you urgently under the two-week-wait pathway in line with NICE guidance on suspected cancer (NG12), as this can occasionally indicate a biliary or pancreatic cause requiring prompt investigation.

For people with a confirmed diagnosis of NAFLD or MASLD, NICE guidance (NG49) recommends risk stratification using a blood test called FIB-4 (adjusted for age). Those with an indeterminate or high FIB-4 score should be assessed further using enhanced liver fibrosis (ELF) testing or transient elastography (FibroScan), with referral to specialist services according to local integrated care board (ICB) pathways.^[8][9] This structured monitoring applies to people with a confirmed diagnosis, not to everyone who has risk factors.

• Seek same-day urgent assessment for jaundice with pale stools and dark urine

• Call 999 or go to A&E for melaena, or heavy or ongoing rectal bleeding with systemic features

• Contact your GP urgently or call NHS 111 for fresh rectal bleeding without systemic features, or if you are unsure

• Book a routine GP appointment for persistent greasy or floating stools, unexplained weight loss, or ongoing abdominal discomfort

• Attend structured monitoring if you have a confirmed diagnosis of NAFLD or MASLD, as recommended by your GP or specialist

Early investigation gives the best opportunity to identify the underlying cause and manage liver disease before it progresses to more serious stages such as fibrosis or cirrhosis.

Scientific References

1. Global epidemiological patterns and disease burden of metabolic dysfunction-associated steatotic liver disease, metabolic dysfunction and alcohol-associated liver disease, and alcohol-associated liver disease.
2. EASL position paper on preclinical models of steatotic liver disease.
3. Jaundice.
4. Symptoms – Primary biliary cholangitis.
5. Neonatal Cholestasis: A Primer of Selected Etiologies.
6. Recognizing Exocrine Pancreatic Insufficiency in Patients with Diabetes: A Case Study.
7. Suspected cancer: recognition and referral (NG12).
8. Metabolic dysfunction-associated steatotic liver disease (NG49).
9. Evaluation and comparison of six noninvasive tests for prediction of significant or advanced fibrosis in nonalcoholic fatty liver disease.
10. LIVERFASt for assessing and monitoring liver fibrosis, activity and steatosis.
11. Gastric varices: a contemporary review of vascular anatomy and therapeutic strategies.
12. Prior Decompensation Identifies Patients at High Mortality Risk Despite Standard Therapy After Variceal Hemorrhage: An Individual Patient Data Meta-Analysis.

Frequently Asked Questions